Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis

Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis

FT.com

Published

With revenues having more than doubled since 2019, to $10bn, US pharma group targets painkillers

Full Article